查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2147148

乳房X光檢查市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Mammography Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

乳房X光檢查市場的成長要素

全球乳房X光檢查市場預估2025年達到138.6億美元，2026年達到143.1億美元，2034年達到193.7億美元，預測期內複合年成長率（CAGR）為3.9%。北美地區在2025年將佔據市場主導地位，市佔率高達73.09%，這得益於其先進的醫療基礎設施、有利的保險報銷政策、完善的乳癌篩檢專案以及先進乳房攝影影像技術的高普及率。乳房X光檢查仍然是乳癌發病率的上升和人們對早期檢測意識的增強，其需求也在不斷成長。

市場定義和範圍

乳房X光攝影是指用於檢測、診斷和後續觀察乳房異常（尤其是乳癌）的影像服務和技術。該市場涵蓋篩檢性乳房X光攝影服務、診斷性乳房X光攝影服務和乳房X光攝影引導介入服務。影像技術包括2D數位乳房X光乳房X光攝影、3D數位乳房斷層合成（DBT）、對比增強乳房X光攝影及其他技術。隨著人工智慧技術的進步、影像視覺化技術的改進以及基於風險的篩檢方法的日益普及，乳房X光攝影服務的範圍正在醫院、專科診所和診斷中心不斷擴大。

市場動態

成長要素

有組織的乳癌篩檢計畫的擴展是市場成長的主要驅動力。各國政府、醫療機構和癌症協會都在提高公眾對篩檢的認知，並建議定期檢查以支持癌症的早期發現。醫療保健支出的成長、診斷基礎設施的改善以及先進乳房攝影技術的廣泛應用，進一步推動了市場成長。 2026年4月，美國國家綜合癌症網路（NCCN）修訂了其乳癌篩檢指南，引入了基於人工智慧的乳房X光攝影風險評估，並將篩檢年齡從35歲開始。這顯示技術驅動的個人化篩檢正發揮著日益重要的作用。

趨勢

關鍵趨勢之一是人工智慧驅動的3D數位乳房斷層合成（DBT）技術的日益普及。到2025年，3D DBT服務將佔據全球市場50.6%的佔有率。 DBT透過提供不同角度的多張乳房攝影，提高組織可見度並減少組織重疊。人工智慧輔助系統還能幫助放射科醫師識別可疑病變、確定病例優先順序並提高工作流程效率。 2026年4月，GE醫療擴大了與DeepHealth的合作，在全球推廣整合「Breast Suite」和「Pristina Via」的人工智慧乳房X光攝影解決方案。

阻礙因素

先進乳房X光攝影系統的高昂成本仍是市場發展的一大限制因素。數位乳房斷層合成（DBT）系統、人工智慧成像軟體和對比增強乳房X光攝影平台都需要在設備、基礎設施、維護和專業人員方面進行大量投資。小規模的醫院和區域診斷中心在採用這些技術方面可能會面臨困難，尤其是在醫療資金籌措和保險覆蓋範圍仍然有限的市場。

新冠疫情的影響

新冠疫情期間，由於預約延長、醫療機構限制開放、病患數量減少等因素，乳房X光檢查服務一度中斷。然而，隨著醫療系統恢復預防性篩檢項目，市場逐漸復甦。對早期診斷的日益重視以及數位醫療技術的應用，也進一步推動了乳房X光檢查數量的恢復。

細分分析

按服務

此市場細分包括篩檢性乳房X光攝影服務、診斷性乳房X光攝影服務和乳房X光攝影引導介入服務。預計到2025年，在預防性醫療保健舉措、乳癌意識提高和系統性篩檢計畫的推動下，篩檢性乳房X光攝影服務將佔據領先地位。受影像引導乳房手術需求不斷成長的驅動，乳房X光攝影引導介入服務預計在預測期內將以5.9%的複合年成長率成長。

透過影像診斷方法

該市場涵蓋2D數位數位乳房攝影服務、3D數位乳房斷層合成（DBT）服務和對比增強乳房X光攝影服務。在組織視覺化和診斷能力提升的推動下，3DDBT細分市場預計到2025年將佔據50.6%的市場佔有率。對比增強乳房X光攝影服務預計將以5.3%的複合年成長率成長，這主要得益於其在複雜乳房攝影檢查中應用的日益廣泛。

最終用戶

終端用戶群包括醫院、專科診所和診斷中心。預計到2025年，醫院憑藉其先進的影像基礎設施和一體化的乳癌診療服務，將佔據領先地位。到2026年，醫院市佔率將達到43.9%。專科診所預計在預測期內將以4.5%的複合年成長率成長。

區域趨勢

北美仍是最大的區域市場，預計到2025年將達到101.3億美元。該地區受益於先進的醫療基礎設施、有利的保險報銷機制、完善的篩檢項目以及人工智慧和數位行為療法（DBT）技術的高普及率。預計到2026年，美國市場規模將達到約101.1億美元，約佔全球市場規模的70.6%。

在以人群為基礎的篩檢項目和先進的診斷基礎設施的支持下，預計到 2026 年，歐洲市場規模將達到 21.3 億美元。英國市場預估到 2026 年規模約 2.4 億美元，德國市場規模約 4 億美元。

受乳癌發生率上升、醫療成本增加以及診斷基礎設施改善等因素推動，亞太地區預計2026年乳癌防治市場規模將達11.8億美元。其中，預計中國市場規模約5.1億美元，日本約3.3億美元，印度約8,000萬美元。

預計到2026年，拉丁美洲市場規模將達到約3.4億美元，海灣合作理事會（GCC）市場規模預計將達到8,000萬美元，南非市場規模預計將達到約3,000萬美元。

報告範圍

這份全球乳房X光檢查市場報告涵蓋了2025年、2026年和2034年的市場規模和預測數據，以及市場動態、趨勢、按服務、影像方法和最終用戶分類的市場細分和區域分析。報告還檢驗了技術進步、人工智慧整合、篩檢項目、監管趨勢、合作關係、競爭策略和關鍵產業發展。報告涵蓋的主要企業包括RadNet, Inc.、InHealth Group、SimonMed Imaging、Akumin Inc.、Fortis Healthcare Ltd.、Affidea Group、Unilabs、Evidia Group和I-MED Radiology Network。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家癌症盛行率
  • 乳房X光攝影技術的進步
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：2021-2034年全球乳房X光檢查市場分析、洞察與預測

  • 市場分析、洞察與預測：按服務分類
    • 乳房X光檢查服務
    • 診斷性乳房X光檢查服務
    • 乳房X光引導介入服務
  • 市場分析、洞察與預測：以成像方式分類
    • 2D數位乳房攝影服務
    • 3D數位乳房斷層合成服務
    • 對比增強乳房X光檢查服務
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 專科診所
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美乳房X光檢查市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲乳房X光檢查市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區乳房X光檢查市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲乳房X光檢查市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲乳房X光檢查市場分析、洞察與預測（2021-2034年）

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • RadNet, Inc.
    • InHealth Group
    • SimonMed Imaging
    • Akumin Inc.
    • Fortis Healthcare Ltd.
    • InHealth Group
    • Affidea Group
    • Unilabs
    • Evidia Group
    • I-MED Radiology Network
Product Code: FBI118257

Growth Factors of mammography Market

The global mammography market was valued at USD 13.86 billion in 2025 and is projected to reach USD 14.31 billion in 2026 and USD 19.37 billion by 2034, registering a CAGR of 3.9% during the forecast period. North America dominated the market with a 73.09% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, established breast cancer screening programs, and high adoption of advanced breast imaging technologies. Mammography remains a critical imaging technique for breast cancer screening and diagnosis, with increasing demand supported by rising disease incidence and growing awareness of early detection.

Market Definition and Scope

Mammography comprises imaging services and technologies used to detect, diagnose, and monitor breast abnormalities, particularly breast cancer. The market includes screening mammography services, diagnostic mammography services, and mammography-guided interventional services. Imaging modalities include 2D digital mammography, 3D digital breast tomosynthesis (DBT), contrast-enhanced mammography, and other technologies. Increasing integration of artificial intelligence, improved image visualization, and risk-based screening approaches are expanding the scope of mammography services across hospitals, specialty clinics, and diagnostic centers.

Market Dynamics

Drivers

The expansion of organized breast cancer screening programs is a major driver of market growth. Governments, healthcare organizations, and cancer societies are increasing screening awareness and encouraging routine examinations to support early cancer detection. Growing healthcare expenditure, improved diagnostic infrastructure, and increasing adoption of advanced breast imaging are further supporting market expansion. In April 2026, the NCCN updated breast cancer screening guidelines to include AI-based mammogram risk assessment beginning at age 35, highlighting the increasing role of technology-supported personalized screening.

Trends

A major trend is the growing adoption of AI-enabled 3D digital breast tomosynthesis. In 2025, the 3D DBT services segment accounted for 50.6% of the global market. DBT provides multiple breast images from different angles, improving tissue visualization and reducing tissue overlap. AI-supported systems further assist radiologists in identifying suspicious lesions, prioritizing cases, and improving workflow efficiency. In April 2026, GE HealthCare expanded its collaboration with DeepHealth to globally commercialize AI-powered mammography solutions integrating Breast Suite with Pristina Via.

Restraints

The high cost of advanced mammography systems remains a key market restraint. DBT systems, AI-enabled imaging software, and contrast-enhanced mammography platforms require significant investment in equipment, infrastructure, maintenance, and trained professionals. Smaller hospitals and rural diagnostic centers may face difficulties adopting these technologies, particularly in markets where healthcare funding and reimbursement coverage remain limited.

Impact of COVID-19

The COVID-19 pandemic temporarily disrupted mammography services because of postponed screening appointments, healthcare facility restrictions, and reduced patient visits. However, the market gradually recovered as healthcare systems resumed preventive screening programs. Increased emphasis on early diagnosis and the adoption of digital healthcare technologies subsequently supported the recovery of mammography screening volumes.

Segmentation Analysis

By Service

The market is segmented into screening mammography services, diagnostic mammography services, and mammography-guided interventional services. Screening mammography services held a major position in 2025, supported by preventive healthcare initiatives, increasing breast cancer awareness, and organized screening programs. Mammography-guided interventional services are projected to grow at a 5.9% CAGR during the forecast period, supported by increasing demand for image-guided breast procedures.

By Imaging Modality

The market includes 2D digital mammography services, 3D digital breast tomosynthesis services, contrast-enhanced mammography services, and others. The 3D DBT segment held a 50.6% share in 2025, supported by improved tissue visualization and diagnostic performance. Contrast-enhanced mammography services are expected to expand at a 5.3% CAGR, supported by increasing utilization in complex breast imaging examinations.

By End User

The end-user segment comprises hospitals, specialty clinics, diagnostic centers, and others. Hospitals held the leading position in 2025 due to advanced imaging infrastructure and integrated breast cancer care. The hospitals segment is expected to account for 43.9% in 2026. Specialty clinics are projected to grow at a 4.5% CAGR during the forecast period.

Regional Insights

North America remained the largest regional market, reaching USD 10.13 billion in 2025. The region benefits from advanced healthcare infrastructure, favorable reimbursement, established screening programs, and high adoption of AI and DBT technologies. The U.S. market is expected to reach approximately USD 10.11 billion in 2026, representing about 70.6% of global market value.

Europe is expected to reach USD 2.13 billion in 2026, supported by population-based screening programs and advanced diagnostic infrastructure. The U.K. market is estimated at approximately USD 0.24 billion, while Germany is projected at approximately USD 0.40 billion in 2026.

Asia Pacific is projected to reach USD 1.18 billion in 2026, supported by rising breast cancer incidence, increasing healthcare expenditure, and improving diagnostic infrastructure. China is expected to reach approximately USD 0.51 billion, Japan approximately USD 0.33 billion, and India approximately USD 0.08 billion in 2026.

Latin America is projected to reach approximately USD 0.34 billion in 2026, while the GCC market is expected to reach USD 0.08 billion. South Africa is projected to reach approximately USD 0.03 billion in 2026.

Competitive Landscape

The global mammography market has a semi-consolidated structure, with leading companies focusing on collaborations, technology development, imaging infrastructure expansion, and AI-enabled services. Major companies include RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., Fortis Healthcare Ltd., Affidea Group, Unilabs, Evidia Group, and I-MED Radiology Network.

In June 2026, FUJIFILM India announced the first installation of its AI-powered AMULET SOPHINITY digital mammography system at NM Medical in India. The system combines low-dose imaging, AI-assisted workflows, and enhanced visualization.

Key Industry Developments

  • June 2026: Devonport Community and Health Services Centre opened Tasmania's first permanent breast screening clinic on the North West Coast, increasing screening capacity for more than 4,000 eligible women annually.
  • April 2026: GE HealthCare expanded its collaboration with DeepHealth to deploy AI-powered mammography solutions globally.
  • April 2026: NCCN incorporated AI-based mammographic risk assessment into breast cancer screening guidance beginning at age 35.
  • December 2025: SP Medifort Hospital partnered with Rotary District 3211 to launch free AI-powered thermal mammography screening camps across Kerala.
  • November 2025: Wichita Radiological Group selected DeepHealth's Operations Suite to modernize imaging operations and improve mammography workflow management.

Report Coverage

The global mammography market report covers market size and forecast data for 2025, 2026, and 2034, along with market dynamics, trends, segmentation by service, imaging modality, and end user, and regional analysis. The report also examines technological advancements, AI integration, screening programs, regulatory developments, partnerships, competitive strategies, and key industry developments. Major companies profiled include RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., Fortis Healthcare Ltd., Affidea Group, Unilabs, Evidia Group, and I-MED Radiology Network.

Conclusion

The global mammography market, valued at USD 13.86 billion in 2025, is projected to increase to USD 14.31 billion in 2026 and reach USD 19.37 billion by 2034 at a 3.9% CAGR. Expanding breast cancer screening programs, increasing adoption of 3D DBT, AI-enabled mammography, personalized screening strategies, and improving diagnostic infrastructure will remain important growth factors. North America's 73.09% market share in 2025 demonstrates its strong market leadership, while Asia Pacific is expected to offer significant future opportunities as healthcare infrastructure and breast cancer awareness continue to improve.

Segmentation By Service, Imaging Modality, End-User, and Region

By Service

  • Screening Mammography Services
  • Diagnostic Mammography Services
  • Mammography-guided Interventional Services

By Imaging Modality

  • 2D Digital Mammography Services
  • 3D Digital Breast Tomosynthesis Services
  • Contrast-enhanced Mammography Services
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

By Region

  • North America (By Service, Imaging Modality, End-User, and Country)
    • U.S.
  • By Service
    • Canada
  • By Service
  • Europe (By Service, Imaging Modality, End-User, and Country/Sub-region)
    • Germany
  • By Service
    • U.K.
  • By Service
    • France
  • By Service
    • Spain
  • By Service
    • Italy
  • By Service
    • Scandinavia
  • By Service
    • Rest of Europe
  • By Service
  • Asia Pacific (By Service, Imaging Modality, End-User, and Country/Sub-region)
    • China
  • By Service
    • Japan
  • By Service
    • India
  • By Service
    • Australia
  • By Service
    • Southeast Asia
  • By Service
    • Rest of Asia Pacific
  • By Service
  • Latin America (By Service, Imaging Modality, End-User, and Country/Sub-region)
    • Brazil
  • By Service
    • Mexico
  • By Service
    • Rest of Latin America
  • By Service
  • Middle East & Africa (By Service, Imaging Modality, End-User, and Country/Sub-region)
    • GCC
  • By Service
    • South Africa
  • By Service
    • Rest of Middle East & Africa
  • By Service

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Prevalence of Cancer, Key Countries, 2025
  • 4.2. Technological Advancements in Mammography
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Service
    • 5.1.1. Screening Mammography Services
    • 5.1.2. Diagnostic Mammography Services
    • 5.1.3. Mammography-guided Interventional Services
  • 5.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 5.2.1. 2D Digital Mammography Services
    • 5.2.2. 3D Digital Breast Tomosynthesis Services
    • 5.2.3. Contrast-enhanced Mammography Services
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Diagnostic Centres
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa

6. North America Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Service
    • 6.1.1. Screening Mammography Services
    • 6.1.2. Diagnostic Mammography Services
    • 6.1.3. Mammography-guided Interventional Services
  • 6.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 6.2.1. 2D Digital Mammography Services
    • 6.2.2. 3D Digital Breast Tomosynthesis Services
    • 6.2.3. Contrast-enhanced Mammography Services
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Diagnostic Centres
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Service
    • 6.4.2. Canada
      • 6.4.2.1. By Service

7. Europe Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Service
    • 7.1.1. Screening Mammography Services
    • 7.1.2. Diagnostic Mammography Services
    • 7.1.3. Mammography-guided Interventional Services
  • 7.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 7.2.1. 2D Digital Mammography Services
    • 7.2.2. 3D Digital Breast Tomosynthesis Services
    • 7.2.3. Contrast-enhanced Mammography Services
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Diagnostic Centres
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Service
    • 7.4.2. Germany
      • 7.4.2.1. By Service
    • 7.4.3. France
      • 7.4.3.1. By Service
    • 7.4.4. Spain
      • 7.4.4.1. By Service
    • 7.4.5. Italy
      • 7.4.5.1. By Service
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Service
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Service

8. Asia Pacific Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Service
    • 8.1.1. Screening Mammography Services
    • 8.1.2. Diagnostic Mammography Services
    • 8.1.3. Mammography-guided Interventional Services
  • 8.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 8.2.1. 2D Digital Mammography Services
    • 8.2.2. 3D Digital Breast Tomosynthesis Services
    • 8.2.3. Contrast-enhanced Mammography Services
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Centres
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Service
    • 8.4.2. Australia
      • 8.4.2.1. By Service
    • 8.4.3. China
      • 8.4.3.1. By Service
    • 8.4.4. India
      • 8.4.4.1. By Service
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Service
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Service

9. Latin America Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service
    • 9.1.1. Screening Mammography Services
    • 9.1.2. Diagnostic Mammography Services
    • 9.1.3. Mammography-guided Interventional Services
  • 9.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 9.2.1. 2D Digital Mammography Services
    • 9.2.2. 3D Digital Breast Tomosynthesis Services
    • 9.2.3. Contrast-enhanced Mammography Services
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Centres
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Service
    • 9.4.2. Mexico
      • 9.4.2.1. By Service
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Service

10. Middle East and Africa Mammography Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Service
    • 10.1.1. Screening Mammography Services
    • 10.1.2. Diagnostic Mammography Services
    • 10.1.3. Mammography-guided Interventional Services
  • 10.2. Market Analysis, Insights and Forecast - By Imaging Modality
    • 10.2.1. 2D Digital Mammography Services
    • 10.2.2. 3D Digital Breast Tomosynthesis Services
    • 10.2.3. Contrast-enhanced Mammography Services
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostic Centres
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. South Africa
      • 10.4.1.1. By Service
    • 10.4.2. GCC
      • 10.4.2.1. By Service
    • 10.4.3. Rest of Middle East and Africa
      • 10.4.3.1. By Service

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. RadNet, Inc.
    • 11.2.2. InHealth Group
    • 11.2.3. SimonMed Imaging
    • 11.2.4. Akumin Inc.
    • 11.2.5. Fortis Healthcare Ltd.
    • 11.2.6. InHealth Group
    • 11.2.7. Affidea Group
    • 11.2.8. Unilabs
    • 11.2.9. Evidia Group
    • 11.2.10. I-MED Radiology Network

List of Tables

  • Table 1: Global Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 2: Global Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 3: Global Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 4: Global Mammography Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 6: North America Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 7: North America Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 8: North America Mammography Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 9: U.S. Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 10: Canada Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 11: Europe Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 12: Europe Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 13: Europe Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 14: Europe Mammography Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 15: U.K. Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 16: Germany Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 17: France Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 18: Spain Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 19: Italy Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 20: Scandinavia Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 21: Rest of Europe Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 22: Asia Pacific Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 23: Asia Pacific Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 24: Asia Pacific Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 25: Asia Pacific Mammography Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 26: Japan Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 27: Australia Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 28: China Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 29: India Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 30: Southeast Asia Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 31: Rest of Asia Pacific Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 32: Latin America Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 33: Latin America Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 34: Latin America Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 35: Latin America Mammography Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 36: Brazil Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 37: Mexico Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 38: Rest of Latin America Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 39: Middle East and Africa Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 40: Middle East and Africa Mammography Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
  • Table 41: Middle East and Africa Mammography Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 42: Middle East and Africa Mammography Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 43: GCC Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 44: South Africa Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034
  • Table 45: Rest of Middle East and Africa Mammography Market Revenue (USD billion) Forecast, By Service, 2021-2034

List of Figures

  • Figure 1: Global Mammography Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Mammography Market Value Share (%), By Service, 2025 & 2034
  • Figure 3: Global Mammography Market Value Share (%), By Imaging Modality, 2025 & 2034
  • Figure 4: Global Mammography Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Mammography Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Mammography Market Value (USD billion), By Service, 2025 & 2034
  • Figure 7: North America Mammography Market Value Share (%), By Service, 2025
  • Figure 8: North America Mammography Market Value (USD billion), By Imaging Modality, 2025 & 2034
  • Figure 9: North America Mammography Market Value Share (%), By Imaging Modality, 2025
  • Figure 10: North America Mammography Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Mammography Market Value Share (%), by End-user, 2025
  • Figure 12: North America Mammography Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Mammography Market Value Share (%), By Country, 2025
  • Figure 14: Europe Mammography Market Value (USD billion), By Imaging Modality, 2025 & 2034
  • Figure 15: Europe Mammography Market Value Share (%), By Imaging Modality, 2025
  • Figure 16: Europe Mammography Market Value (USD billion), By Service, 2025 & 2034
  • Figure 17: Europe Mammography Market Value Share (%), By Service, 2025
  • Figure 18: Europe Mammography Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Mammography Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Mammography Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 21: Europe Mammography Market Value Share (%), By Country/Sub-region, 2025
  • Figure 22: Asia Pacific Mammography Market Value (USD billion), By Service, 2025 & 2034
  • Figure 23: Asia Pacific Mammography Market Value Share (%), By Service, 2025
  • Figure 24: Asia Pacific Mammography Market Value (USD billion), By Imaging Modality, 2025 & 2034
  • Figure 25: Asia Pacific Mammography Market Value Share (%), By Imaging Modality, 2025
  • Figure 26: Asia Pacific Mammography Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Mammography Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Mammography Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Mammography Market Value Share (%), By Country/Sub-region, 2025
  • Figure 30: Latin America Mammography Market Value (USD billion), By Service, 2025 & 2034
  • Figure 31: Latin America Mammography Market Value Share (%), By Service, 2025
  • Figure 32: Latin America Mammography Market Value (USD billion), By Imaging Modality, 2025 & 2034
  • Figure 33: Latin America Mammography Market Value Share (%), By Imaging Modality, 2025
  • Figure 34: Latin America Mammography Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Mammography Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Mammography Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 37: Latin America Mammography Market Value Share (%), By Country/Sub-region, 2025
  • Figure 38: Middle East and Africa Mammography Market Value (USD billion), By Service, 2025 & 2034
  • Figure 39: Middle East and Africa Mammography Market Value Share (%), By Service, 2025
  • Figure 40: Middle East and Africa Mammography Market Value (USD billion), By Imaging Modality, 2025 & 2034
  • Figure 41: Middle East and Africa Mammography Market Value Share (%), By Imaging Modality, 2025
  • Figure 42: Middle East and Africa Mammography Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East and Africa Mammography Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East and Africa Mammography Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 45: Middle East and Africa Mammography Market Value Share (%), By Country/Sub-region, 2025
  • Figure 46: Global Mammography Market Share (%), By Company, 2025